Fan Le-Wei, Li Yun-Ren, Wu Cheng-Mu, Chuang Kai-Ti, Li Wei-Chang, Liu Chung-Yi, Chang Ying-Hsu
Division of Urology, Department of Surgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital and Chang Gung University, New Taipei 236, Taiwan.
Department of Biotechnology and Laboratory Science in Medicine, National Tang Ming Chiao Tung University, Taipei 112, Taiwan.
J Clin Med. 2024 Jan 29;13(3):772. doi: 10.3390/jcm13030772.
Bladder cancer is a common urinary tract malignancy. Minimally invasive radical cystectomy has shown oncological outcomes comparable to the conventional open surgery and with advantages over the open procedure. However, outcomes of the two main minimally invasive procedures, robot-assisted and pure laparoscopic, have yet to be compared. This study aimed to compare in-hospital outcomes between these two techniques performed for patients with bladder cancer. This population-based, retrospective study included hospitalized patients aged ≥ 50 years with a primary diagnosis of bladder cancer who underwent robot-assisted or pure laparoscopic radical cystectomy. All patient data were extracted from the US National Inpatient Sample (NIS) database 2008-2018 and were analyzed retrospectively. Primary outcomes were in-hospital mortality, prolonged length of stay (LOS), and postoperative complications. The data of 3284 inpatients (representing 16,288 US inpatients) were analyzed. After adjusting for confounders, multivariable analysis revealed that patients who underwent robot-assisted radical cystectomy had a significantly lower risk of in-hospital mortality (adjusted OR [aOR], 0.50, 95% CI: 0.28-0.90) and prolonged LOS (aOR, 0.63, 95% CI: 0.49-0.80) than those undergoing pure laparoscopic cystectomy. Patients who underwent robot-assisted radical cystectomy had a lower risk of postoperative complications (aOR, 0.69, 95% CI: 0.54-0.88), including bleeding (aOR, 0.73, 95% CI: 0.54-0.99), pneumonia (aOR, 0.49, 95% CI: 0.28-0.86), infection (aOR, 0.55, 95% CI: 0.36-0.85), wound complications (aOR, 0.33, 95% CI: 0.20-0.54), and sepsis (aOR, 0.49, 95% CI: 0.34-0.69) compared to those receiving pure laparoscopic radical cystectomy. Patients with bladder cancer, robot-assisted radical cystectomy is associated with a reduced risk of unfavorable short-term outcomes, including in-hospital mortality, prolonged LOS, and postoperative complications compared to pure laparoscopic radical cystectomy.
膀胱癌是一种常见的泌尿系统恶性肿瘤。微创根治性膀胱切除术的肿瘤学结局已显示出与传统开放手术相当,且具有优于开放手术的优势。然而,两种主要的微创手术,即机器人辅助手术和单纯腹腔镜手术的结局尚未进行比较。本研究旨在比较为膀胱癌患者实施的这两种技术的院内结局。这项基于人群的回顾性研究纳入了年龄≥50岁、初步诊断为膀胱癌且接受机器人辅助或单纯腹腔镜根治性膀胱切除术的住院患者。所有患者数据均从2008 - 2018年美国国家住院样本(NIS)数据库中提取,并进行回顾性分析。主要结局为院内死亡率、住院时间延长以及术后并发症。分析了3284例住院患者的数据(代表16288名美国住院患者)。在对混杂因素进行调整后,多变量分析显示,与接受单纯腹腔镜根治性膀胱切除术的患者相比,接受机器人辅助根治性膀胱切除术的患者院内死亡风险显著降低(调整后的比值比[aOR]为0.50,95%置信区间[CI]:0.28 - 0.90),住院时间延长的风险也降低(aOR为0.63,95% CI:0.49 - 0.80)。接受机器人辅助根治性膀胱切除术的患者术后并发症风险较低(aOR为0.69,95% CI:0.54 - 0.88),包括出血(aOR为0.73,95% CI:0.54 - 0.99)、肺炎(aOR为0.49,95% CI:0.28 - 0.86)、感染(aOR为0.55,95% CI:0.36 - 0.85)、伤口并发症(aOR为0.33,95% CI:0.20 - 0.54)和脓毒症(aOR为0.49,95% CI:0.34 - 0.69)。对于膀胱癌患者,与单纯腹腔镜根治性膀胱切除术相比,机器人辅助根治性膀胱切除术与不良短期结局风险降低相关,包括院内死亡率、住院时间延长和术后并发症。